Molecular screening for fragile X syndrome in children with unexplained intellectual disability and/or autistic behaviour


	Clinical presentation of the selected patients based on the leading clinical criteria for inclusion in the study. Some of the patients presented with more than one feature so that the total number of the patients on the chart exceeds the number of selected group.

Part of: Stoyanova M, Hachmeriyan M, Levkova M, Bichev S, Georgieva M, Mladenov V, Angelova L (2022) Molecular screening for fragile X syndrome in children with unexplained intellectual disability and/or autistic behaviour. Folia Medica 64(1): 27-32. https://doi.org/10.3897/folmed.64.e60518